ALXP
ALKLH
Market cap52mUSD
Oct 28, Last price
0.15EUR
1D
9.29%
1Q
-3.16%
IPO
-21.54%
Name
Visiomed Group SA
Chart & performance
P/E
20.63
P/S
2.12
EPS
0.01
Vol. 1Y
50.54%
Shs. 5Y
—
Rev. 5Y
-4.28%
Div Yld LY
—
Div Yld TTM
—
Revenues
22m
Net income
2m
CFO
5m
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Klea Holding SA, along with its subsidiaries, provides healthcare technology solutions and related services across France and internationally. The company's key offerings include BewellConnect, a comprehensive health ecosystem that facilitates augmented and assisted teleconsultation, remote patient monitoring for both home and hospital settings, tele-expertise, virtual assistance, and remote regulatory services. Additionally, Klea Holding SA markets Smart Salem, a specialized device for medical fitness assessments. Founded in 2007 and headquartered in Paris, France, the company operated under the name Visiomed Group SA until it rebranded to Klea Holding SA in June 2024.
Key people
Guillaume Bremond
Chairman of the Board · since 2022
Clement Pacaud
Chief Executive Officer, Director · since 2024
Raphael Smila
Director · since 2024
Anne Gaignard
Independent Director · since 2022
Axel Richebraque
Independent Director
Headquarters & legal address
14 RUE DE COURCELLES
16
PARIS 75008
FR
16
PARIS 75008
FR
Previous name
VISIOMED GROUP
Valuation
Title EUR in thousands, except ratios and share amounts | FY |
|---|---|
| 2025‑12 | |
| Income | |
Revenues | |
Cost of revenue | |
Unusual Expense (Income) | |
NOPBT | |
NOPBT Margin | |
Operating Taxes | |
Tax Rate | |
NOPAT | |
Net income | |
Dividends | |
Dividend yield | |
Proceeds from repurchase of equity | |
BB yield | |
| Debt | |
Debt current | |
Long-term debt | |
Deferred revenue | |
Other long-term liabilities | |
Net debt | |
| Cash flow | |
Cash from operating activities | |
CAPEX | |
Cash from investing activities | |
Cash from financing activities | |
FCF | |
| Balance | |
Cash | |
Long term investments | |
Excess cash | |
Stockholders' equity | |
Invested Capital | |
ROIC | |
ROCE | |
| EV | |
Common stock shares outstanding | |
Price | |
Market cap | |
EV | |
EBITDA | |
EV/EBITDA | |
Interest | |
Interest/NOPBT | |